Please provide your email address to receive an email when new articles are posted on . This analysis focused on adults with moderate to severe COPD without an exacerbation during the ENHANCE trials.
The researchers found that compared with those without dyspnea, patients with postadmission-onset dyspnea had sixfold higher odds of death during hospitalization. HealthDay News — For non-intensive ...
Medically reviewed by Laura Campedelli, DPT Key Takeaways Common causes of shortness of breath include physical ...
Post-COVID syndrome is here. It's been reported by the lay press and by multiple non-peer-reviewed medical sites, including Medscape. People with persistent symptoms have been called "long-haulers," ...
Please provide your email address to receive an email when new articles are posted on . Patients who received an initial diagnosis with point-of-care ultrasonography (POCUS) vs. the standard of care ...
A yearly influenza vaccine reduces serious illness and death in COPD patients by nearly 50%. Pneumococcal polysaccharide vaccine is also recommended for COPD patients aged 65 years and older or those ...
Editor's note: Find the latest long COVID news and guidance in Medscape's Long COVID Resource Center. Poor-quality sleep and irregular sleep could be important drivers of breathlessness in patients ...